Background information on HIV, hepatitis C and STIs in Canada, including basic information, statistics (epidemiology), provincial and national strategies to address HIV, hepatitis C and STIs, and social determinants of health.
CATIE strengthens Canada’s response to HIV and hepatitis C by bridging research and practice. We connect healthcare and community-based service providers with the latest science, and promote good practices for prevention and treatment programs.
Clinical trials in Canada to explore reducing inflammation in HIV
For details of clinical trials in Canada to explore reducing inflammation in HIV, see TreatmentUpdate 225.